|
HY-100554-10mg
|
MedChemexpress LLC
|
BMY 7378 [CAS 21102-95-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101454-10mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-100mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-25mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-5mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101454-50mg
|
MedChemexpress LLC
|
SR0987 [CAS 303126-97-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101876-10mg
|
MedChemexpress LLC
|
Rhodamine 800 [CAS 137993-41-0]
|
|
|
|
|
HY-101876-25mg
|
MedChemexpress LLC
|
Rhodamine 800 [CAS 137993-41-0]
|
|
|
|
|
HY-10209-10mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-100mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-200mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-5mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209-50mg
|
MedChemexpress LLC
|
Masitinib [CAS 790299-79-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-10mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-100mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-200mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-5mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-50mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-103177-10mg
|
MedChemexpress LLC
|
PSB-10 (hydrochloride) [CAS 591771-91-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-103177-5mg
|
MedChemexpress LLC
|
PSB-10 (hydrochloride) [CAS 591771-91-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-103387-1mg
|
MedChemexpress LLC
|
DuP-697 [CAS 88149-94-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-103387-10mg
|
MedChemexpress LLC
|
DuP-697 [CAS 88149-94-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-103387-5mg
|
MedChemexpress LLC
|
DuP-697 [CAS 88149-94-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-106934-10mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
|
HY-106934-100mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
